The US and EU regulatory perspectives on the clinical use of hematopoietic stem/progenitor cells genetically modified ex vivo by retroviral vectors (Q45882176)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The US and EU regulatory perspectives on the clinical use of hematopoietic stem/progenitor cells genetically modified ex vivo by retroviral vectors |
scientific article |
Statements
1 reference
The US and EU regulatory perspectives on the clinical use of hematopoietic stem/progenitor cells genetically modified ex vivo by retroviral vectors (English)
1 reference
Carolyn A Wilson
1 reference
Klaus Cichutek
1 reference
1 January 2009
1 reference
506
1 reference
477-488
1 reference